Zi Lin

Quick links to important sections

Zi Lin

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zi Lin

Zilin is a brand name for the prescription antibiotic medicine Linezolid. It is primarily used to treat serious bacterial infections, particularly those that have shown resistance to common first-line antibiotics. Zilin is available in several forms, including oral tablets and intravenous (IV) injection. Its use is strictly regulated to preserve its effectiveness against resistant bacteria.


Quick Facts

Property Description
Active Ingredient Linezolid
Form Tablet, IV Injection
Pharmacological Class Oxazolidinone Antibiotic
Common Use Treating certain types of pneumonia and serious skin/soft tissue infections

Pharmacological Class and Unique Action

Linezolid belongs to the oxazolidinone class, which is clinically recognized for its unique mechanism of action compared to older antibiotics. It functions as a protein synthesis inhibitor, stopping bacteria from being able to multiply by blocking the crucial initial step in their ability to build proteins.

A key differentiating feature of Linezolid is its effectiveness against highly resistant strains of bacteria, such as Methicillin-Resistant Staphylococcus aureus (MRSA). Because of this powerful and distinct activity, it is often reserved for treating severe bacterial illnesses like hospital-acquired pneumonia and complicated skin and soft tissue infections. Its high oral bioavailability means that the oral form is almost completely absorbed, often allowing patients to safely switch from IV to oral therapy.

What side effects are possible with Zi Lin?

Possible Side Effects and Safety Information

Official regulatory documents classify the adverse reactions associated with Linezolid (Zi Lin) across several physiological systems. The risk profile is structurally defined by the potential for Systemic Toxicity, specifically affecting the blood and nervous systems.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by their observed frequency, primarily following the standards used in documents such as the EMA Summary of Product Characteristics (SmPC):

Classification Examples of Documented Effects
Common Diarrhea, Headache, Nausea, Vomiting, Dizziness, Anemia, Thrombocytopenia (low platelet count), Oral or Vaginal Moniliasis (thrush).
Uncommon Peripheral neuropathy, Seizures/Convulsions, Hypertension, Renal failure, Hypoglycemia (low blood sugar), Pancytopenia.
Rare Visual field defect, Sideroblastic anemia, Transient superficial tooth discoloration, Rhabdomyolysis.

Serious Adverse Reactions and Safety Constraints

Official labeling highlights several serious adverse reactions, including the risk of Myelosuppression (severe blood disorders), Lactic Acidosis (a metabolic condition), and Serotonin Syndrome (a potentially life-threatening reaction, particularly when co-administered with serotonergic agents). Peripheral and Optic Neuropathy are reported primarily in patients treated for longer than the maximum recommended duration, establishing a duration-dependent risk pattern. Safety constraints also mandate the avoidance of large amounts of Tyramine-containing foods and beverages due to the potential for a hypertensive reaction. Specific safety considerations are required for patients with severe renal or hepatic impairment, where monitoring of blood counts is essential.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Official regulatory documents describe documented manifestations in the context of acute toxicity, which include nausea, vomiting, diarrhea, headache, and dizziness. More severe toxicity affects the Central Nervous System (CNS) and metabolic function. The official profile notes the potential for Lactic Acidosis, the occurrence of convulsions (seizures), and the risk of Serotonin Syndrome, particularly when the drug is co-administered with serotonergic agents.


When to Seek Urgent Medical Help

Regulators mandate that immediate medical attention or emergency services must be contacted if critical symptoms are observed, such as collapse, difficulty breathing, seizures, or if the individual cannot be awakened. Urgent medical evaluation is also required for signs like severe gastrointestinal symptoms, changes in vision, or unusual bleeding or bruising. These actions are required due to the severity of the documented systemic risks.


Management and Supportive Measures

Treatment for Linezolid overdose is strictly symptomatic and supportive, as official labeling confirms that no specific antidote is known. Supportive measures documented in regulatory guidance include the use of hemodialysis, which is known to remove approximately 30% of the drug dose. Additionally, patients with severe renal impairment require closer monitoring during overdose management due to the reduced clearance of drug metabolites.

Therapeutic Uses of Zi Lin

Zi Lin is applied across domains where additional symptomatic support is needed in contexts involving acute or disruptive episodes. It is applied in contexts involving serious conditions, including certain types of pneumonia and complicated skin and soft tissue infections. Its therapeutic use supports the reduction of the overall symptom burden in conditions characterized by periods of heightened symptoms.

Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

The medicine is often used in clinical settings that involve acute or unstable symptom patterns, and is relevant when symptoms escalate temporarily. It is considered relevant for easing symptoms associated with systemic or localized discomfort.

“This medication is applied across domains where additional symptomatic support is needed for managing serious infections.”

By providing supportive relief, Zi Lin may assist patients with coping more steadily with symptom fluctuations and helps maintain a sense of functional stability during episodes of high physiological stress.

Eligibility and Restrictions for Use

Zi Lin (Linezolid) is an antibiotic whose use is defined by strict population eligibility rules, primarily documented by regulatory bodies like the FDA and EMA.

Populations Prohibited from Use (Contraindications)

Category Official Regulatory Status
Hypersensitivity Contraindicated in patients with a known allergy to Linezolid or any of its components.
MAOI Use Contraindicated in patients currently taking Monoamine Oxidase Inhibitors (MAOIs) or within two weeks of stopping such medications.

Restricted and Conditional Use

Population / Condition Eligibility Restriction
Pregnancy Use is permitted only if the potential benefit justifies the potential risk to the fetus.
Lactation Not recommended; a clinical decision must be made to discontinue nursing or the medicine.
Severe Renal Impairment Use is conditional, requiring special caution due to the accumulation of non-active metabolites.
Severe Hepatic Impairment Restricted, as safety and efficacy data have not been established in this population.
Age Groups Approved for adults and pediatric patients (from birth). Geriatric patients do not require a dose adjustment.

Regulatory documents limit Zi Lin to populations without specific pre-existing conditions (e.g., MAOI use) or physiological vulnerabilities (e.g., severe hepatic status), ensuring the drug is only administered when deemed appropriate under official label guidance.

What should I know about interactions with other medicines?

Zi Lin (Linezolid) has officially documented interaction patterns that primarily stem from its function as a reversible, non-selective Monoamine Oxidase Inhibitor. This classification dictates specific restrictions and mandatory timing rules. Co-administration with other Monoamine Oxidase Inhibitors (MAOIs) is contraindicated, and use must be separated by at least two weeks.

The most critical pharmacodynamic interactions involve Serotonergic Agents, such as SSRIs and SNRIs, due to the risk of Serotonin Syndrome, a serious central nervous system reaction. Regulatory labeling requires a mandatory separation period before starting Zi Lin, which is typically two weeks, extending to five weeks for agents with longer half-lives like Fluoxetine. Resumption of these agents may occur 24 hours after the final dose of Zi Lin.

Furthermore, Zi Lin requires dietary restrictions. The consumption of Tyramine-rich foods and beverages (e.g., aged cheeses, fermented meats) may lead to a pressor response and potential hypertensive crisis. Similar risks exist with certain Adrenergic Agents (e.g., Pseudoephedrine). The drug is officially documented as not being a clinically relevant inhibitor or inducer of major Cytochrome P450 enzymes. Regarding food, a high-fat meal reduces the drug's maximum concentration (Cmax) by about 17%, though the total drug exposure (AUC) remains unchanged.

Mechanism of Action

Core Mechanism: Ribosomal Inhibition

Zi Lin (Linezolid) executes its primary pharmacological effect by functioning as an inhibitor of bacterial protein synthesis. The molecule acts upon the 23 S ribosomal RNA component within the 50 S ribosomal subunit. By binding to the peptidyl transferase center, the drug physically blocks the formation of the 70 S initiation complex, which is essential for the bacteria to begin translating genetic material into proteins. This initial block in the translation pathway immediately disrupts bacterial replication and inhibits the growth of susceptible pathogens.

️ Secondary Host Modulation

A distinct consequence of the drug's chemical structure is its secondary, reversible inhibition of Monoamine Oxidase (MAO) enzymes (MAO-A and MAO-B). As MAO is responsible for metabolizing neurotransmitters like serotonin and norepinephrine, the engagement of this host metabolic pathway results in the altered metabolism and accumulation of monoamines within the nervous system. The drug's functional effectiveness is constrained by resistance mechanisms, such as the acquisition of the cfr gene, which chemically modifies the ribosomal binding site, thereby interfering with the core inhibitory mechanism.

Dosage and Administration Information

How to Use Zi Lin (Linezolid): Administration Guidelines

Zi Lin, the brand name for the antibiotic Linezolid, is administered according to specific protocols concerning its dosage, route, and timing. The medicine is available as 600 mg tablets, a 100 mg/5 mL oral suspension, and a 2 mg/ mL solution for intravenous (IV) infusion.

Standard Dosing and Route

The standard dosage for adults and adolescents (ge 12 years) is 600 mg administered every 12 hours (twice daily). The maximum recommended total daily dose is 1,200 mg. The medicine can be given orally or intravenously.

Because Zi Lin is nearly 100% absorbed when taken by mouth, no dose adjustment is necessary when switching a patient from the IV infusion to the oral tablet or suspension.

Population Dose & Frequency Course Duration
Adults (ge 12 yrs) 600 mg every 12 hours 10 to 14 or 14 to 28 days
Pediatrics (Birth–11 yrs) 10 mg/ kg every 8 hours 10 to 14 or 14 to 28 days

Administration Details

Instruction Category Procedural Rule
Timing with Meals May be administered without regard to the timing of meals (with or without food).
IV Administration Must be given as an IV infusion over a period of 30 to 120 minutes; no additives should be introduced into the infusion bag.
Missed Dose Take the missed dose as soon as possible, but do not double doses to make up for a missed one.
Dose Adjustments No dose adjustment is required for older adults or in cases of renal or hepatic impairment. For patients receiving hemodialysis, the dose should be administered after the dialysis session.

Recent Clinical Evidence

Research Evidence Overview for Zi Lin (Linezolid)

Zi Lin, which contains the antibiotic Linezolid, has been the subject of extensive clinical research primarily focused on severe bacterial infections resistant to common treatments. The evidence base includes a combination of Randomized Controlled Trials (RCTs), systematic reviews, and observational studies, with trials typically monitoring outcomes over short to intermediate follow-up periods.


Evidence for Key Indications

Research has explored Zi Lin's use in Complicated Skin and Soft Tissue Infections (cSSTIs), where trials measured clinical resolution and the microbiological eradication of pathogens like Methicillin-Resistant Staphylococcus aureus (MRSA). In the context of Hospital-Acquired Pneumonia, studies evaluated clinical success rates and survival in hospitalized adults with severe infections. For rare infections, such as those caused by Vancomycin-Resistant Enterococcus faecium (VRE), research relies on smaller clinical investigations and observational data, where findings described patterns in microbiological response and patient outcomes.


Research Gaps and Limitations

The existing evidence highlights several limitations. Follow-up durations were limited in the main trials, meaning long-term effects are not fully established regarding infection recurrence or functional recovery months after treatment. For rare conditions like VRE, the sample sizes were modest, and the reliance on non-randomized data means that subgroup findings are uncertain. Additionally, data for certain special populations, such as all pediatric age groups (especially infants), are less extensive compared to adult populations.

Frequently Asked Questions (FAQ)

Common questions about Zi Lin (FAQ)

Q: Are there any common over-the-counter medicines that interact with Zi Lin?

According to official labeling, Linezolid is a reversible Monoamine Oxidase (MAO) inhibitor, meaning it can potentially interact with certain other substances. This includes some common over-the-counter medicines containing ingredients such as pseudoephedrine or phenylephrine (often found in cold or decongestant medications). The official product information notes the importance of disclosing all OTC products to a healthcare professional.

Q: Are the side effects of Zi Lin permanent?

Official safety information indicates that many reported side effects are generally temporary and reversible. However, a duration-dependent risk exists for serious side effects like peripheral neuropathy and optic neuropathy (nerve damage in the eyes or limbs). These specific conditions may be irreversible, and they are more often reported in individuals treated for longer than the maximum recommended duration.

Q: Can Zi Lin cause mood changes?

The official labeling includes mental/mood changes as reported side effects. Official labeling states that monitoring for these effects is warranted, as well as for insomnia (trouble sleeping) and episodes of acute confusion. These symptoms are related to the drug's secondary activity as a Monoamine Oxidase inhibitor.

Q: What is the purpose of the different strengths of Zi Lin tablets?

Zi Lin is available in various forms and strengths, such as tablets and oral suspension. Official product information states that having these different strengths allows healthcare professionals to choose the appropriate dose based on the specific infection, as well as the patient's age and weight.

Q: Does taking Zi Lin with food reduce stomach upset?

Official administration guidelines state that Linezolid can be taken with or without food, as food does not significantly change the drug’s absorption. While common side effects include stomach problems like diarrhea, nausea, and vomiting, the regulatory information does not explicitly state that taking the medicine with food reduces these gastrointestinal effects.

Q: Is it necessary to have regular blood tests while on Zi Lin?

Yes, regulatory warnings state that complete blood counts are recommended to be monitored weekly while taking this medicine. Monitoring is stated as particularly important when treatment lasts longer than two weeks or in the presence of pre-existing low blood cell counts. This monitoring is necessary due to the risk of serious blood disorders like myelosuppression.

Q: Can people who are allergic to other medicines still use Zi Lin?

Official documentation explicitly states that Zi Lin is contraindicated (not recommended for use) in people with a known hypersensitivity or allergic reaction to the active ingredient, Linezolid, or any of its components. Allergies to other, unrelated medicines are not a direct contraindication, but a patient’s full allergy history is a factor for professional review.

Q: Is it common for people to feel tired when taking Zi Lin?

Official side effect lists do not explicitly name 'fatigue' or 'tiredness' as common effects. However, common reported effects include dizziness and headache. Furthermore, the drug carries a warning for a serious metabolic condition, lactic acidosis, which can cause generalized feelings of weakness and being very tired.

Q: Does Zi Lin affect sleep patterns?

Yes, the official drug label for Linezolid lists insomnia (trouble sleeping) as a common undesirable effect. This means it is among the more frequently reported side effects observed in clinical studies.

Q: What happens if you stop taking Zi Lin suddenly?

Official guidance notes that stopping the medication without professional input is not recommended. Stopping an antibiotic too soon risks incomplete treatment, meaning the infection may not be fully resolved. This also contributes to the critical public health issue of antibiotic resistance.

Q: Is Zi Lin a controlled substance?

Zi Lin is a prescription-only medication. The regulatory status indicates it is not classified as a controlled substance by the US Drug Enforcement Administration (DEA), which means it has no federally recognized potential for abuse or dependency.

Q: Is Zi Lin safe for people who drive or operate machinery?

The official product information includes a warning that individuals should be aware of the potential for side effects like dizziness or visual impairment. The official product information advises against driving or operating machinery if these symptoms occur while taking Zi Lin.

Q: Are there known interactions between Zi Lin and herbal supplements?

The drug’s label notes the importance of disclosing all herbal products or supplements to a healthcare professional. This is especially important for products that could increase the risk of Serotonin Syndrome, such as the herbal remedy St. John's Wort.

Q: Can men and women use Zi Lin for the same conditions?

The official indications for Linezolid are based on the type of severe bacterial infection and are not specific to gender. However, non-clinical toxicology data does indicate that the drug may decrease fertility in men.

Q: Is Zi Lin an anti-inflammatory drug?

No, the official regulatory classification for Linezolid is as an antibacterial agent (an antibiotic). The drug works by uniquely stopping the growth of bacteria through inhibiting protein synthesis and is not classified as an anti-inflammatory medication.

Q: Is Zi Lin addictive?

Zi Lin is a prescription-only drug. Its regulatory classification confirms it is not a controlled substance, indicating it has no recognized potential for abuse or dependence.

Q: Are there any common vitamins that interact with Zi Lin?

Official patient information notes the importance of disclosing all concomitant products, including vitamins/minerals, to a healthcare professional. This is necessary to properly review the potential interaction profile of the drug.

Q: Can Zi Lin cause skin reactions or rashes?

Yes, common undesirable effects listed in the official product information include rash and pruritus (itching). The regulatory post-marketing data also indicates reports of serious, sometimes life-threatening, skin reactions.

Q: How is Zi Lin eliminated from the body?

Official pharmacokinetics data shows that Linezolid is eliminated from the body primarily via the urine. It is cleared both as the parent drug and in the form of two inactive metabolites. Non-renal clearance processes account for approximately 65% of the drug's total clearance.

How should Zi Lin be stored and disposed of?

Official Storage and Disposal Requirements for Zi Lin (Linezolid)

The storage and disposal of Zi Lin (Linezolid) must strictly follow official regulatory guidelines to maintain product quality and ensure environmental safety.

Requirement Area Official Labeled Mandate
Temperature & Packaging Store tablets and the oral suspension at Controlled Room Temperature (20^circC to 25^circC). Keep the product in its original container.
IV Solution Handling The IV injection solution must not be frozen. Keep the infusion bag in its overwrap until immediately before use to protect it from light. Inspect the solution for particles or discoloration before use.
Stability After Preparation The reconstituted oral suspension is stable for and must be used within 21 days after mixing.
Disposal Do not dispose of unused or expired medicine via wastewater (toilet/sink) or household trash. Return the medicine to a designated collection point, following local pharmaceutical waste regulations.
Child Safety Keep this medicine out of the sight and reach of children.

These constraints define the proper conditions for the drug's quality and handling, from required temperature control to the mandatory environmentally safe disposal of unused quantities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zi Lin found in:

A-Z Index: